These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 38829739

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney.
    Brinkley G, Nam H, Shim E, Kirkman R, Kundu A, Karki S, Heidarian Y, Tennessen JM, Liu J, Locasale JW, Guo T, Wei S, Gordetsky J, Johnson-Pais TL, Absher D, Rakheja D, Challa AK, Sudarshan S.
    Dis Model Mech; 2020 Nov 27; 13(11):. PubMed ID: 32928875
    [Abstract] [Full Text] [Related]

  • 3. SHISA3 Reprograms Tumor-Associated Macrophages Toward an Antitumoral Phenotype and Enhances Cancer Immunotherapy.
    Zhang S, Yu B, Sheng C, Yao C, Liu Y, Wang J, Zeng Q, Mao Y, Bei J, Zhu B, Chen S.
    Adv Sci (Weinh); 2024 Sep 27; 11(36):e2403019. PubMed ID: 39054639
    [Abstract] [Full Text] [Related]

  • 4. IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.
    Beyranvand Nejad E, Labrie C, van Elsas MJ, Kleinovink JW, Mittrücker HW, Franken KLMC, Heink S, Korn T, Arens R, van Hall T, van der Burg SH.
    J Immunother Cancer; 2021 Apr 27; 9(4):. PubMed ID: 33879600
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Blocking LTB4 signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy.
    Yan J, Zhu J, Li X, Yang R, Xiao W, Huang C, Zheng C.
    Phytomedicine; 2023 Oct 27; 119():154968. PubMed ID: 37531900
    [Abstract] [Full Text] [Related]

  • 8. Dietary Commensal Wrestles Iron from Tumor Microenvironment to Activate Antitumoral Macrophages.
    Lee AH, Randhawa SK, Meisel M.
    Cancer Res; 2024 Aug 01; 84(15):2400-2402. PubMed ID: 38832925
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Renal L-2-hydroxyglutarate dehydrogenase activity promotes hypoxia tolerance and mitochondrial metabolism in Drosophila melanogaster.
    Mahmoudzadeh NH, Heidarian Y, Tourigny JP, Fitt AJ, Beebe K, Li H, Luhur A, Buddika K, Mungcal L, Kundu A, Policastro RA, Brinkley GJ, Zentner GE, Nemkov T, Pepin R, Chawla G, Sudarshan S, Rodan AR, D'Alessandro A, Tennessen JM.
    Mol Metab; 2024 Nov 01; 89():102013. PubMed ID: 39182840
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
    Lacal PM, Atzori MG, Ruffini F, Scimeca M, Bonanno E, Cicconi R, Mattei M, Bernardini R, D'Atri S, Tentori L, Graziani G.
    Pharmacol Res; 2020 Sep 01; 159():104957. PubMed ID: 32485280
    [Abstract] [Full Text] [Related]

  • 14. Signaling metabolite L-2-hydroxyglutarate activates the transcription factor HIF-1α in lipopolysaccharide-activated macrophages.
    Williams NC, Ryan DG, Costa ASH, Mills EL, Jedrychowski MP, Cloonan SM, Frezza C, O'Neill LA.
    J Biol Chem; 2022 Feb 01; 298(2):101501. PubMed ID: 34929172
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Construction of Hierarchically Biomimetic Iron Oxide Nanosystems for Macrophage Repolarization-Promoted Immune Checkpoint Blockade of Cancer Immunotherapy.
    Kang Y, Yan J, Han X, Wang X, Wang Y, Song P, Su X, Rauf A, Jin X, Pu F, Zhang H.
    ACS Appl Mater Interfaces; 2024 Jul 17; 16(28):36131-36141. PubMed ID: 38979627
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.
    Ma S, Sun B, Duan S, Han J, Barr T, Zhang J, Bissonnette MB, Kortylewski M, He C, Chen J, Caligiuri MA, Yu J.
    Nat Immunol; 2023 Feb 17; 24(2):255-266. PubMed ID: 36658237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.